Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bristol-Myers Squibb (BMY)
NYSE:BMY
Bristol-Myers Squibb (BMY) Ownership Overview
0.07% Insiders
21.76% Mutual Funds
16.11% Other Institutional Investors
23.48% ETFs
38.58% Public Companies and Individual Investors
The ownership structure of Bristol-Myers Squibb (BMY) stock is a mix of institutional, retail, and individual investors. Approximately 61.35% of the company’s stock is owned by Institutional Investors, 0.07% is owned by Insiders, and 38.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 19, 2025 | Samit Hirawat Evp,chief Med.offr.,drug Dev | xxxxxxxxxxxxx | $99973 |
| Nov 05, 2024 | Samit Hirawat Evp,chief Med.offr.,drug Dev | xxxxxxxxxxxxx | $100046 |
| Nov 05, 2024 | Phil M Holzer Svp & Controller | xxxxxxxxxxxxx | $38927 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $539582 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1129276 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1646744 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3959200 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 165,236,511 | Institution | 8.14% | 8,906,247,943 | |
| 136,837,921 | Institution | 6.74% | 7,375,563,942 | |
| 81,109,123 | Institution | 4.00% | 4,371,781,730 | |
| 75,880,316 | Institution | 3.74% | 4,089,949,032 | |
| 54,026,998 | Institution | 2.66% | 2,912,055,192 | |
| 33,733,998 | Institution | 1.66% | 1,818,262,492 | |
| 22,773,180 | Institution | 1.12% | 1,227,474,402 | |
| 19,059,657 | Institution | 0.94% | 1,027,315,512 | |
| 17,129,229 | Institution | 0.84% | 923,265,443 | |
| 16,461,475 | Institution | 0.81% | 887,273,503 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 136,837,921 | Institution | 6.74% | 7,375,563,942 | |
| 33,733,998 | Institution | 1.66% | 1,818,262,492 | |
| 16,461,475 | Institution | 0.81% | 887,273,503 | |
| 14,050,207 | Institution | 0.69% | 757,306,157 | |
| 12,726,086 | Institution | 0.63% | 685,936,035 | |
| 11,822,839 | Institution | 0.58% | 637,251,022 | |
| 10,593,542 | Institution | 0.52% | 570,991,914 | |
| 10,367,907 | Institution | 0.51% | 558,830,187 | |
| 9,100,858 | Institution | 0.45% | 490,536,246 | |
| 9,056,095 | Institution | 0.45% | 488,123,521 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 63,588,943 | Institution | 3.13% | 3,596,590,616 | |
| 54,926,306 | Institution | 2.71% | 3,106,631,867 | |
| 48,227,018 | Institution | 2.38% | 2,699,266,197 | |
| 24,835,623 | Institution | 1.22% | 1,390,049,819 | |
| 24,835,623 | Institution | 1.22% | 1,390,049,819 | |
| 23,796,747 | Institution | 1.17% | 1,282,644,663 | |
| 17,274,567 | Institution | 0.85% | 977,049,510 | |
| 14,399,324 | Institution | 0.71% | 805,930,164 | |
| 9,053,389 | Institution | 0.45% | 506,718,182 | |
| 8,827,202 | Institution | 0.43% | 494,058,496 |
FAQ
Who Owns Bristol-Myers Squibb (BMY)?
According to the latest TipRanks data, approximately 16.11% of the company's stock is held by institutional investors, 0.07% is held by insiders, and 38.58% is held by retail investors.
What percentage of Bristol-Myers Squibb (BMY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.11% of Bristol-Myers Squibb (BMY) stock is held by institutional investors.
What percentage of Bristol-Myers Squibb (BMY) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.58% of Bristol-Myers Squibb (BMY) stock is held by retail investors.
Who owns the most shares of Bristol-Myers Squibb (BMY)?
Vanguard owns the most shares of Bristol-Myers Squibb (BMY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.